Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR:: A possible hot spot?

被引:60
作者
Cascón, A
Montero-Conde, C
Ruiz-Liorente, S
Mercadillo, F
Letón, R
Rodríguez-Antona, C
Martinez-Delgado, B
Delgado, M
Díez, A
Rovira, A
Díaz, JA
Robledo, M
机构
[1] Ctr Nacl Invest Oncol, Dept Human Genet, Hereditary Endocrine Canc Grp, Madrid 28029, Spain
[2] Hosp Bierzo, Dept Endocrinol, Ponferrada, Spain
[3] Fdn Jimenez Diaz, Dept Endocrinol, E-28040 Madrid, Spain
[4] Hosp Univ Clin San Carlos, Dept Endocrinol, Madrid, Spain
关键词
D O I
10.1002/gcc.20283
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pheochromocytoma and paraganglioma are rare neuroendocrine tumors that arise in the adrenal medulla and the extra-adrenal paraganglia, respectively. Inheritance of these tumors is mainly a result of mutations affecting the VHL, RET NFI, and SDH genes. Germ-line mutations of the SDH genes have been found to account for nearly 10% of apparently sporadic cases. Nevertheless, alterations other than point mutations have not yet been well characterized. In this study, we investigated the frequency of gross SDH deletions in 24 patients who tested negative for point mutations and had at least one of the recommended features for genetic testing. For this purpose, we used a technique that is easy to implement in the lab to specifically detect gross deletions affecting SDHB, SDHC, and SDHD. We identified 3 heterozygous SDHB deletions (3/24) in 3 independent cases with paraganglioma: 1 whole SDHB deletion and 2 deletions exclusively affecting exon 1. These latter mutations match the unique gross deletion previously reported, indicating this region could be a hot spot for gross SDHB deletions. It seems likely that these alterations can account for a considerable number of both familial and apparently sporadic paraganglioma cases. Although this is the first report describing the presence of gross deletions in patients with apparently sporadic paragangliomas, the extra-adrenal location of the tumor seems to constitute a determining factor for whether to include these patients in genetic testing for gross deletions in the SDHB gene. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 18 条
  • [1] Anderson Robert J., 1993, Current Opinion in Oncology, V5, P75
  • [2] Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma
    Astuti, D
    Latif, F
    Dallol, A
    Dahia, PLM
    Douglas, F
    George, E
    Sköldberg, F
    Husebye, ES
    Eng, C
    Maher, ER
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (01) : 49 - 54
  • [3] An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma
    Baysal, BE
    Willett-Brozick, JE
    Filho, PAA
    Lawrence, EC
    Myers, EN
    Ferrell, RE
    [J]. JOURNAL OF MEDICAL GENETICS, 2004, 41 (09) : 703 - 709
  • [4] Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
    Baysal, BE
    Ferrell, RE
    Willett-Brozick, JE
    Lawrence, EC
    Myssiorek, D
    Bosch, A
    van der Mey, A
    Taschner, PEM
    Rubinstein, WS
    Myers, EN
    Richard, CW
    Cornelisse, CJ
    Devilee, P
    Devlin, B
    [J]. SCIENCE, 2000, 287 (5454) : 848 - 851
  • [5] Molecular profiling of inflammatory breast cancer:: Identification of a poor-prognosis gene expression signature
    Bièche, I
    Lerebours, F
    Tozlu, S
    Espie, M
    Marty, M
    Lidereau, R
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6789 - 6795
  • [6] Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD
    Dannenberg, H
    van Nederveen, FH
    Abbou, M
    Verhofstad, AA
    Komminoth, P
    de Krijger, RR
    Dinjens, WNM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 1894 - 1901
  • [7] Gimenez-Roqueplo AP, 2003, CANCER RES, V63, P5615
  • [8] The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors
    Kolomietz, E
    Meyn, MS
    Pandita, A
    Squire, JA
    [J]. GENES CHROMOSOMES & CANCER, 2002, 35 (02) : 97 - 112
  • [9] LACK EE, 1997, TUMORS ADRENAL GLAND, V3
  • [10] Phenotypic expression in von Hippel-Lindau disease: Correlations with germline VHL gene mutations
    Maher, ER
    Webster, AR
    Richards, FM
    Green, JS
    Crossey, PA
    Payne, SJ
    Moore, AT
    [J]. JOURNAL OF MEDICAL GENETICS, 1996, 33 (04) : 328 - 332